Mice treated with an immunostimulant had better outcomes when researchers blocked the expression of TNFR2, a compound that helps tumors evade immune attack.
Scientists at this month’s AACR meeting highlighted research on the crucial role of the non-malignant cells that surround tumors in cancer initiation, growth, and response.